Gsa Capital Partners LLP X4 Pharmaceuticals, Inc Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$0.72 - $1.46 $449,388 - $911,259
-624,150 Reduced 66.04%
321,021 $446,000
Q4 2023

Feb 16, 2024
BUY
$0.61 - $0.99 $197,386 - $320,348
323,584 Added 52.06%
945,171 $793,000
Q3 2023

Nov 15, 2023
BUY
$1.03 - $2.02 $640,234 - $1.26 Million
621,587 New
621,587 $677,000

Others Institutions Holding XFOR

# of Institutions
107
Shares Held
101M
Call Options Held
418K
Put Options Held
71.7K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $45.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email